fda stops semaglutide compounding Compounded TrimRX | FDA Halts Sales

Soc., London 1980, A298, 495

Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway

Identity (LC-MS) Verified Utilizes LC-MS analysis to confirm the molecular identity of the compound

Ideal for patients needing a motivational boost at the start of their journey 4

In a recent article in Science, chemist Derek Lowe points out two other instances of missed opportunities: (1) the head of research at Schering-Plough, which now manufactures Claritin, once said that there arent any nonsedating antihistamines and (2) when a large pharma company decided not to develop metformin to treat type 2 diabetes

Whether through cutting-edge pharmaceuticals or smart wearables, optimizing health is now more accessible than ever